Ann: Appendix 4C and Quarterly Update, page-29

Hi Adreamer and NZT,

its easy. Instead of chatting about objective matters in a subjective way.

Talk about objective matters in an objective way.

Both of you write to the Company to get the subject Novartis/ Elanco come whoever has it now Patent.

I dare you both and no more discussion on the patent till you have it.

Adreamer, you say the Company is transparent and truthful. NZT you somewhat disagree.

I will call you both out, if you don't produce the data and still subjectively talk about it. Make sure of that !

Remember last announcement previous to the 30/01/2023 about the patents was August 30 2020 , whereby it states " it should be noted that the Elanco/ Novartis patent begin to expire in 2023"

Bet you good money they won't give you what you are after.

Remember, I know much more than what I say on HC. You both know that.